While the potential benefits of 3D bioprinting in epidemiology are significant, there are also important ethical considerations. Issues related to the use of human cells, the potential for creating fully functional organs, and the long-term effects of bioprinted tissues need to be carefully considered. Regulatory frameworks will need to evolve to address these challenges and ensure that the technology is used responsibly.
